RSSCategory: Pharmaceuticals

China’s Ebola vaccine enters clinical trials

December 21, 2014

BEIJING – An Ebola vaccine developed by a military research institute has been approved to enter the human test stage, the Chinese People’s Liberation Army’s (PLA) General Logistics Department announced Thursday. The restructured vaccine, developed by the Academy of Military […]

Continue Reading

New diabetes drug given nod by health ministry

December 18, 2014

Dubai: The Ministry of Health has announced that a groundbreaking non-insulin injection for people with Type 2 diabetes now has marketing authorisation. The drug will dramatically improve glycaemic control in patients and effectively slow down the diabetes epidemic. The injection […]

Continue Reading

Antibiotics resistance could kill 10m a year by 2050

December 16, 2014

The region with the highest number of deaths attributable to antimicrobial resistance would be Asia with 4.7 million A British government-commissioned review has found that resistance to antibiotics could account for 10 million deaths a year and hit global gross […]

Continue Reading

HSA warns of illegal weight loss pills

December 14, 2014

The Health Sciences Authority (HSA) yesterday alerted the public to two illegal weight loss products which have landed two people in hospital. After taking Nutri Drops Grapefruit Diet for more than a month, a female teen suffered hallucinations and was […]

Continue Reading

Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS(R) (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting

December 12, 2014

SAN FRANCISCO – Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited (TSE:4502) today reported data demonstrating that Hodgkin lymphoma (HL) patients at risk of relapse following an autologous stem cell transplant (ASCT) who received ADCETRIS (brentuximab vedotin) as consolidation therapy […]

Continue Reading

Takeda’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by U.S. FDA for Relapsed or Refractory Systemic Light-chain Amyloidosis

December 10, 2014

SINGAPORE – Takeda Pharmaceutical Company Limited  today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy status to the company’s investigational, oral proteasome inhibitor, ixazomib (MLN9708), for the treatment of relapsed or refractory systemic light-chain (AL) […]

Continue Reading

Anti-HIV drugs supply to increase in Myanmar

December 2, 2014

Myanmar’s health ministry plans to increase the supply of anti-HIV drugs from 60 percent to 95 percent for people infected with the human immunodeficiency virus by 2015, officials said Tuesday. According to a survey, about 120,000 patients carrying HIV do […]

Continue Reading

$2 million worth of illegal diet pills seized in Thailand

November 26, 2014

In a raid yesterday, soldiers and related officials seized Sibutramine-laced diet pills worth Bt50 million (S$2 million) in Phitsanulok’s Muang district. Consumers have also been urged to drop off any of these pills they may have at the Damrongtham Centre. […]

Continue Reading

Fertility drugs up leukaemia risk in kids

November 25, 2014

Children born to mothers who took fertility drugs to get pregnant are at increased risk of developing leukaemia, French scientists have revealed. They found that children were 2.6 times more likely to become ill with acute lymphoblastic leukaemia (ALL), the […]

Continue Reading

Astellas aims to introduce cancer medicines in UAE

November 20, 2014

The Japanese drug maker Astellas is looking to introduce one of its best-selling cancer medicines in the UAE – and to start manufacturing drugs in the country by 2019. From its Dubai office, which opened on Thursday, it plans to […]

Continue Reading